Archive
JP Morgan Cazenove lifts target on Glencore
Two heavyweights came together on Monday, with JP Morgan Cazenove posting a note on much-in-the news miner and trader Glencore.
Company
GSK PLC
LON:GSK
GSK PLC will be a fully focused biopharma company following the demerger of its world-leading consumer healthcare business, Haleon, in July 2022. The company will prioritise innovation in vaccines and specialty medicines, maximising the increasing opportunities to prevent and treat disease.
743 stories · page 8 of 8
Investments and investor services
FTSE 100 regains ground as miners rise
The FTSE 100 ended 1.6%, or 96.4 points higher at 6,032.
London shares motor ahead as Volkswagen panic eases
A revival in mining and automotive industry shares lifted indices
Glaxosmithkline reports positive results from HIV drug tests
Data showed switching to once-daily Triumeq maintains HIV viral suppression
Investments and investor services
Crest Nicholson is Goldman's top pick in midst of housing sector's results season
It seems the housing sector has been bouncing back since the current decade began, but brokers seem to agree there is further to go.
Risers & Fallers: Ryanair, Horizon Discovery, ANGLE, Morrisons and GlaxoSmithKline
Below are the main news-driven share price movements at 4pm.
Woodford fund proving a summer favourite for investors
Bio and pharma holdings keep Woodford on top with other healthcare funds also doing well.
Archive
FTSE 100 crashes to eight month low
The top share index fell for the ninth day in a row and finished down 5.5% on the week.
Investments and investor services
FTSE 100 hit by double whammy from China and Greece
It's not quiet a triple digit fall - yet - for Footsie, but it is mighty close.
FTSE 100 falls for ninth day in a row
It's looking like a total capitulation by the bulls as fears grow for Asia-Pacific economic growth prospect
Footsie falls on disappointing Chinese data and Greek chaos
Index drops 47 points as Greece sets date for fresh elections
Risers & Fallers including Marechale Capital, Photonstar, Premier Oil, Glaxo, Fidelity China...
Below are the main new driven share price movements at 4pm.
GlaxoSmithKline sells MS drug rights to Novartis for US$1bn
Deal leaves Novartis as the owner of rights to ofatumumab in all indications
Analysis: Old vs new, Witan and Woodford release interims
Witan one of the UK’s oldest investment trusts, and Woodford Patient Capital Trust, which listed in April, reported first half figures today
Archive
FTSE100 closes lower as Carney's comments spook traders
FTSE100 did not manage to get into positive territory on Thursday and closed down around five points...
Investments and investor services
Shares pare losses on UK interest rate decision
Traders cheered by signs that cost of borrowing may not rise until 2016
Pfizer accused of overcharging NHS for epilepsy drug
The CMA said it believed the two companies abused dominant positions
Investments and investor services
Oil majors drag London market lower as crude prices fall
Miners rise after upbeat results from gold producer Randgold Resources
Investments and investor services
FTSE 100 flies as Glaxo becomes latest subject of bid gossip
The latest pharma bid rumour to surface is Pfizer gunning for Glaxo, but it was the miners that drove Footsie's ascent
FTSE 100 buoyed by miners and more pharma bid gossip
Rio Tinto led the advance ahead of results due out tomorrow
Glaxo to re-emerge from negative cycle, BarCap says
Glaxo, BG, Shell, Domino’s Pizza and TalkTalk are all in Monday’s broker spotlight
Archive
FTSE100 closes higher as eyes turn to Fed
UK shares added 1.16% to close higher on Wednesday....
Investments and investor services
Footsie rises on results cheer before Fed decision
Banks and oil majors rise but Sky shares do a U-turn
GlaxoSmithKline hails new drugs as sales rise
"Sales grew 7% on a reported basis and 2% pro-forma."
Archive
Wednesday's agenda - Sky among the riders as results pour in
Wednesday sees a veritable clutch of results statements from some big guns....
Pearson "eyes more sell-offs" as Nikkei reassures on FT
Pearson could sell stake in Penguin Random House, analysts say
Archive
Broker Spotlight – QinetiQ, BT, Telit , Stanley Gibbons ...
The recent rally in Qinetiq shares has gone too far
Investments and investor services
Risers & Fallers: ARM, BT, Fidelity China Special Situations, GlaxoSmithKline, Hikma, Tesco
Tesco is a top riser on the FTSE 350 by virtue of things getting worse at a slower rate than previously.
Archive
Tuesday's most followed, including inflation, Greece, Ashtead Group and GlaxoSmithKline
The return of UK inflation, Ashtead Group (LON:AHT) and drugs giant Glaxo (LON:GSK) were topics trending in web world this morning as Footsie was on the slide.
Investments and investor services
Risers & fallers: Access Intelligence, Iofina, Danl Stewart, Auhua Clean Energy, PowerFilm, Metminco
Investors took a gamble on Ladbrokes while Ashtead fell despite good results.
Investments and investor services
FTSE 100 opens lower; Greece weighs on markets again
The FTSE 100 was 40 points lower to 6,670 in early deals this morning.
Hardware & electrical equipment
US shares open on the front foot
The FTSE 100 was lower at lunch to 6,681 as Greece remains in stalemate with its creditors.
Wall Street declines amid Greece, China worries; Noble Energy slumps
U.S. stocks dropped on concerns about Greece's precarious financial condition and slowing growth in China, while energy shares fell the most since March, overshadowing gains in small-cap companies. The S&P 500 (INDEXSP:.INX) slid 0.5 pe